Key Sessions
Sarah Snykers
Capacity is No Longer the Limiting Factor of Commercial CAR-T Production, and What Now Determines Commercial Success
Legend Biotech
Gunther Busam
Beyond Manufacturing Scale: Building Sustainable Cell & Gene Therapy Operations
Orchard Therapeutics
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Wednesday 4th November – Day 1 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Clear
Showing 1 of 1 Streams
Gene Therapy Manufacturing & Analytics
11:10 - 11:15
Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics
- Catherine Simpson - Conference Director - Cell and Gene Therapy Portfolio, Informa Connect LifeSciences
11:15 - 11:45
Keynote Panel Discussion: Pioneering Gene Therapy Manufacturing: Tackling Bottlenecks to Scale, Boost Potency, Quality and Lower Costs Per Dose
- Gunther Busam - Vice President, Global Manufacturing Technology and Supply, Orchard Therapeutics
- Christine Le Bec - Deputy CTO, Head of Analytical Development & QC, Sensorion
- Parag Kumthekar - Lead Gene Therapy Downstream Process Development, UCB
11:45 - 12:15
Establishing a Network to Produce Lentiviral Vectors for Carvykti®
- Rutger Douma - MSAT Advanced Therapies Director, Johnson & Johnson Innovative Medicine
Showing 1 of 1 Streams
Gene Therapy Manufacturing & Analytics
14:00 - 14:30
Upstream Innovation to Improve Product Quality and Increase Cell Density in Scalable AAV Production
- Clotilde Ciesla - Upstream Development Engineer, Genethon
14:30 - 15:00
Cell-Free AAV Manufacturing: Redefining Scalability, Quality, and Cost in Gene Therapy
- Jordan Turnbull - Co-Founder, Co-CEO, CSO, Fuse Vectors
15:00 - 15:30
Early CMC Investment Enables Scalable Manufacturing of VTx-002: A First-In-Class AAV-based Vectorized Antibody Targeting TDP-43 in ALS
- Jelmer Willems - Senior Scientist, Group leader, Vector Development, VectorY
Showing 1 of 1 Streams
Gene Therapy Manufacturing & Analytics
16:15 - 16:45
From Bottlenecks to Breakthroughs: Driving Innovation in AAV Downstream Processing for Speed, Scale, and Sustainability
- Parag Kumthekar - Lead Gene Therapy Downstream Process Development, UCB
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
